Product
Ceftazidime or Meropenem
Aliases
Ceftazidime or meropenem
Name
Ceftazidime
INN Name
CEFTAZIDIME
FDA Approved
Yes
1 clinical trial
4 organizations
1 indication
2 documents
Indication
MelioidosisClinical trial
A Randomized, Double-Blind, Placebo-Controlled, Exploratory Study to Assess the Efficacy, Safety and Tolerability of Oral ARV-1801 Given in Combination With Intravenous Ceftazidime or Meropenem for Intensive Phase Therapy of Melioidosis in Hospitalized PatientsStatus: Completed, Estimated PCD: 2023-10-10
Organization
Sagent PharmaceuticalsDocument
DailyMed Label: CeftazidimeOrganization
WG Critical Care, LLCDocument
DailyMed Label: TAZICEFOrganization
Hospira, Inc.Organization
WG Critical Care, LLC.